The partnership will focus on identifying and validating novel drug targets for unmet therapeutic needs for psychiatric symptoms affecting people with mental health conditions
Read More
Swiss group Addex Therapeutics has joined a UK-based initiative established to study the role of the D1 receptor, the main dopamine receptor, in human brain function.
Read More
Cancer Research UK will award up to £71 million to the first four winning teams of its Grand Challenge competition, set up to help overcome the biggest challenges facing cancer researchers in order to accelerate success in the global fight against the disease.
Read More
Cancer Research UK is linking with the Wellcome Trust and investment groups Syncona and BACIT to create a new company, to be listed on the London Stock Exchange with assets of up to £1 billion, that will stream funds into life sciences.
Read More
Four research powerhouses have come together to launch an international project aiming to set up a large, globally accessible, bank of new cancer cell culture models for the research.
Read More
